← Product Code [NLF](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/NLF) · K072194 # RENU REPROCESSED NELLCOR OXIMETRY SENSOR, MODEL D-25, N-25 (K072194) _Renu Medical, Inc. · NLF · Nov 29, 2007 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94cardiovascular-monitoring-devices/NLF/K072194 ## Device Facts - **Applicant:** Renu Medical, Inc. - **Product Code:** [NLF](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/NLF.md) - **Decision Date:** Nov 29, 2007 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.2700 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Pediatric ## Indications for Use Both the ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor are intended as single patient use O2 transducer/accessory sensors for use in conjunction with the Nellcor™ Oximeter system. The Model D-25 is used for patients >30 kg. The Model N-25 is used for neonates <3 kg or adults >40 kg. Both sensors are used for noninvasive monitoring of pulse oxygen hemoglobin saturation (SpO2) and pulse rate. ## Device Story Reprocessed pulse oximetry sensors; function as transducers for oximeter monitoring systems. Input: electrical signals from oximeter; output: patient-modified signals returned to oximeter for analysis/display. Components: two LEDs (light sources), one photodiode (detector), laminated envelope, adhesive bandage, cable with multi-pin connector. Used in clinical settings; operated by healthcare professionals. Provides continuous SpO2 and pulse rate data to assist clinical decision-making; benefits patient through non-invasive monitoring. ## Clinical Evidence Substantial equivalence supported by bench testing, clinical performance data, and non-clinical performance data. Specific metrics not provided in summary. ## Technological Characteristics Optical sensor containing two LEDs and one photodiode. Laminated envelope with adhesive bandage. Cable with multi-pin connector. Designed to meet EN 60601-1, EN 60601-1-2, and biocompatibility standards ISO 10993-10 and EN 30993-1. ## Regulatory Identification An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter. ## Predicate Devices - Nellcor™ D-25 Oximetry sensor - Nellcor™ N-25 Oximetry sensor ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Section 13 Premarket Notification K072194 510 (k) Summary Submitters Name and Address: ReNu Medical, Inc. 9800 Evergreen Way Everett, WA 98024 Phone: 425-353-1110 Fax: 425-353-9116 FDA Registration Number: 3034520 Contact Person: L. Bruce Pierson Chief Operating Officer NOV 2 9 2007 Date Summary Prepared: August 4, 2007 Trade or Proprietary Name(s): ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor, ReNu Medical Reprocessed Nellcor™ N-25 Oximetry Sensor Common Name: Oximetry Sensor Classification: Oximeter (21 CFR 870.2700) / NLF Equivalent Device(s) The ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Nellcor™ N-25 Oximetry Sensor are substantially equivalent to the Nellcor™ D-25 Oximetry sensor and Nellcor™ N-25 Oximetry sensor (respectively), Device Description: The ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor are accessory devices to an oximeter monitoring system. The oxisensor is designed as a transducer for the transmission of electrical signals from the oximeter to the patient and the return of patient modified signals back to the oximeter for analysis and display of patient information. The sensor contains three optical components; two light emitting diodes (LEDs) serve as light sources and one photodiode acting as a light detector LED and sensor are contained in a laminated envelope provided with an adhesive bandage for attachment a patient. A sensor package is attached to a cable terminated in a multi-pin connector that plugs into the oximeter. {1}------------------------------------------------ #### Intended Use Both the ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor are intended as single patient use O2 transducer/accessory sensors for use in conjunction with the Nellcor™ Oximeter system. The Model D-25 is used for patients >30 kg. The Model N-25 is used for neonates <3 kg or adults >40 kg. Both sensors are used for noninvasive monitoring of pulse oxygen hemoglobin saturation (SpO2) and pulse rate. Technological Characteristics of the ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor Compared with the Nellcor™ D-25 Oximetry Sensor and Nellcor™ N-25 Oximetry Sensor The predicate devices and the ReNu Medical Reprocessed devices contain identical components (LED, photodiode, laminated envelope, cable, and connector.) The means of patient attachment (adhesive bandage) is identical. ### Summary of Comparison Tests Based on an assessment consisting of bench testing, clinical performance data, and non-clinical performance data the ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor function in a manner that is Substantially Equivalent to that of the predicate devices. ### Safety and Standards The ReNu Medical Reprocessed Nellcor™ D-25 Oximetry Sensor and Reprocessed Nellcor™ N-25 Oximetry Sensor are designed to meet the following safety standards: - EN 60601-1 t - . EN60601-1-2 - Biocompatibility ISO10993-10 1995 EN 30993-1 . Confidential {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized depiction of an eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The eagle is enclosed within a circle, with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" surrounding it. Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 NOV 2 9 2007 Mr. Bruce Pierson Chief Operating Officer ReNu Medical, Incorporated 9800 Evergreen Way Everett, Washington 98204 Re: K072194 Trade/Device Name: ReNu Reprocessed Nellcor Oximeter Sensor Model D-25, N-25 Regulation Number: 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: NLF Dated: October 26, 2007 Received: October 30, 2007 Dear Mr. Pierson: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ #### Page 2 - Mr. Pierson Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours, Chiu Lin, Ph.D. Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ # Indications for Use 510(k) Number (if known): K072194 Device Name: ReNu Reprocessed Nellcor Oximeter Sensor Model D-25, N-25 Indications For Use: D-25 continuous non-invasive arterial oxygen saturation and pulse rate monitoring of patients > 30 kg. N-25: continuous non-invasive arterial oxygen saturation and pulse rate monitoring of patients foot if < 3 kg, or finger if > 40 kg. XX Prescription Use (Part 21 CFR 801 Subpart D) AND/OR Over-The-Counter Use (21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) unh Yohn . 1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . tion of Anesthesiology, General Hospital. Control, Control, Dental Devices ber: K07 2194 Page 1 of {5}------------------------------------------------ ## List of Models | And Annon Andrews And All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All All
A THE T RE THE FOR
.

.


Call Call of Children


Creasured brodio/Wels !!! Vitters
AAA WARW !!! V
.
-----------------
Achaly White

NY W. Mb
Whitelever
WW
:
----------
14.11V
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
www.vallabour.com

.

100 V

100

ARRE T TO BAR

A C C C . C . C . C . C . C

**WW
.

Clouder
1000

School September
September 1 1 Comments of Children Company Company Company Company Company Company Company Comments of Children Comments of Children Company Company Comments of Children Comm
11 1
.
VV .!
.

.
.

- " " superse" part in " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " "
N
BOOM AND

44. 44. 444-453
- William
10 " " " W
11 . 11 . 11 . 11 .
15 .
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1
A MA JOY 11 Your Nation Nation
Septed Select Collection of
Cameral Lance .
SARE CORPORATION
I
*****
Carlos
Company of the career of the | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| |
| | A to problem on an any of
N A Los Land La Box | | Concession
1
44.60 - 400
1
FREE OF CLASE LEASE
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
A MIC CHANAGE AN AN | : : and the state of the same of the states : : --- **Source:** [https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94cardiovascular-monitoring-devices/NLF/K072194](https://fda.innolitics.com/submissions/AN/subpart-c%E2%80%94cardiovascular-monitoring-devices/NLF/K072194) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com